Accepted at: Nov, 01, 2023
4:37 a.m.
Author:
jaynguyen
Related Deck:
1680834516778
Accepted
Rationale for new note
Not bolded in alikhan, but was emphasized in my didactics and seemed like good thing to know. Feel free to decline
Text
{{c1::Certolizumab pegol}} is a {{c2::TNF-α inhibitor::MOA}} that lacks an IgG Fc region → limits transfer through the placenta and decreases teratogenic potential during pregnancy
Text
{{c1::<b>Certolizumab</b> <b>pegol</b>}} is a {{c2::<b>TNF-α inhibitor</b>::MOA}} that lacks an IgG Fc region → limits transfer through the placenta and <u>decreases teratogenic potential</u> during pregnancy
Extra
PEGylated TNF-α inhibitor → attachment of PEG polymers delays metabolism and increases half-life
Extra
PEGylated TNF-α inhibitor → attachment of PEG polymers delays metabolism and increases half-life
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
DermPath
Empty field
DermPath
Dermoscopy
Empty field
Dermoscopy
VisualDx
Empty field
VisualDx
DermNet
Empty field
DermNet
Full Spectrum of Dermatology
Empty field
Full Spectrum of Dermatology
Dermnemonics
Empty field
Dermnemonics
Dermatographix
Empty field
Dermatographix
Textbook
Empty field
Textbook
Additional Resources
Empty field
Additional Resources
One by one
Empty field
One by one
Tags
#Dermki::Alikhan::02_Dermatopharmacology::02.4_Immunomodulatory_agents
#Dermki::Alikhan::updated::2nd_ed
AnkiHub_Subdeck::Dermki::02_Dermatopharmacology